Stelvio Therapeutics is developing therapies through epigenetics. We have invented a novel platform technology called Microscopic Imaging of Epigenetic Landscapes (MIEL) to unambiguously identify the epigenetic signature of individual cells. This enables discovery of novel small molecules that induce differentiation or reversal of cancerous cells into benign cell types which is potentially curative.